IL-10: A potential therapy for allergic inflammation?

被引:140
作者
Pretolani, M [1 ]
Goldman, M [1 ]
机构
[1] FREE UNIV BRUSSELS,HOP ERASME,DEPT IMMUNOL,B-1070 BRUSSELS,BELGIUM
来源
IMMUNOLOGY TODAY | 1997年 / 18卷 / 06期
关键词
D O I
10.1016/S0167-5699(97)80023-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 10 (IL-10) is currently regarded as a potential therapy for inflammatory diseases involving T helper 1 (Th1)-type responses because of its ability to downregulate several major functions of Th1 cells and macrophages. Here, evidence is provided that IL-10 could also be useful in controlling Th2-mediated inflammatory processes by preventing the accumulation of activated eosinophils in target tissues.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 47 条
[1]   Interleukin-10 inhibits cytokine generation from mast cells [J].
Arock, M ;
ZuanyAmorim, C ;
Singer, M ;
Benhamou, M ;
Pretolani, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :166-170
[2]   IDENTIFICATION OF ACTIVATED LYMPHOCYTES-T AND EOSINOPHILS IN BRONCHIAL BIOPSIES IN STABLE ATOPIC ASTHMA [J].
AZZAWI, M ;
BRADLEY, B ;
JEFFERY, PK ;
FREW, AJ ;
WARDLAW, AJ ;
KNOWLES, G ;
ASSOUFI, B ;
COLLINS, JV ;
DURHAM, S ;
KAY, AB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (06) :1407-1413
[3]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[4]   Expression of RANTES in human airway epithelial cells: Effect of corticosteroids and interleukin-4, -10 and -13 [J].
Berkman, N ;
Robichaud, A ;
Krishnan, VL ;
Roesems, G ;
Robbins, R ;
Jose, PJ ;
Barnes, PJ ;
Chung, KF .
IMMUNOLOGY, 1996, 87 (04) :599-603
[5]   CORTICOSTEROID RESISTANCE IN CHRONIC ASTHMA [J].
CARMICHAEL, J ;
PATERSON, IC ;
DIAZ, P ;
CROMPTON, GK ;
KAY, AB ;
GRANT, IWB .
BRITISH MEDICAL JOURNAL, 1981, 282 (6274) :1419-1422
[6]   INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE [J].
CASSATELLA, MA ;
MEDA, L ;
BONORA, S ;
CESKA, M ;
CONSTANTIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2207-2211
[7]   INTERLEUKIN-10 (IL-10) UP-REGULATES IL-1 RECEPTOR ANTAGONIST PRODUCTION FROM LIPOPOLYSACCHARIDE-STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY DELAYING MESSENGER-RNA DEGRADATION [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
CALZETTI, F ;
BONORA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1695-1699
[8]  
CHERNOFF AE, 1995, J IMMUNOL, V154, P5492
[9]   INTERLEUKIN-4 IS REQUIRED FOR THE INDUCTION OF LUNG TH2 MUCOSAL IMMUNITY [J].
COYLE, AJ ;
LEGROS, G ;
BERTRAND, C ;
TSUYUKI, S ;
HEUSSER, CH ;
KOPF, M ;
ANDERSON, GP .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (01) :54-59
[10]   MONOCYTE CHEMOTACTIC PROTEIN-3 IS A MOST EFFECTIVE BASOPHIL-ACTIVATING AND EOSINOPHIL-ACTIVATING CHEMOKINE [J].
DAHINDEN, CA ;
GEISER, T ;
BRUNNER, T ;
VONTSCHARNER, V ;
CAPUT, D ;
FERRARA, P ;
MINTY, A ;
BAGGIOLINI, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :751-756